Biliary Tract Disease
📧 Sign up to get email alerts when something new happens for Biliary Tract Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-31Clinical Trial Update: Time to Post-operative Recovery of Serum Albumin as a Predictor of Outcome in Major Hepato Pancreato Biliary Surgeries
This clinical trial evaluates whether the time to postoperative recovery of serum albumin can predict outcomes after major hepatopancreatobi…
-
CLINICAL_TRIALS trial_result · 2025-06-17Clinical Trial Update: Clinical Trial for the Optimization of Indocyanine Green Administration in NIRF-C During L.Cholecystectomy. [Phase 4]
A Phase 4 clinical trial investigated how to optimize the administration of indocyanine green for near-infrared fluorescence cholangiography…
-
CLINICAL_TRIALS trial_result · 2025-02-07Clinical Trial Update: Intraperitoneal Ketamine Versus Bupivacaine for Postoperative Pain Control After Laparoscopic Cholecystectomy [EARLY_Phase 1]
Phase 1 trial comparing intraperitoneal ketamine to bupivacaine for postoperative pain control after laparoscopic cholecystectomy has comple…
-
CLINICAL_TRIALS research · 2024-12-06Clinical Trial Update: Comparison of Ultrasound-Guided Quadratus Lumborum Plane Block Versus Intraperitoneal and Periportal Bupivacaine Infiltration in Postoperative Analgesia After Laparoscopic Cholecystectomy [NA]
Clinical trial update comparing ultrasound-guided quadratus lumborum plane block versus intraperitoneal and periportal bupivacaine infiltrat…
-
FDA approval · 2023-10-17FDA Approved: KINEVAC — Supplemental Application (Bracco Diagnostics Inc.)
The FDA approved Bracco Diagnostics' supplemental application for KINEVAC (sincalide), updating its labeling for use in hepatobiliary imagin…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA label_change · 2023-10-17FDA Approved: SINCALIDE — Supplemental Application (MAIA Pharmaceuticals, Inc.)
FDA approved a supplemental application for Sincalide from MAIA Pharmaceuticals, likely affecting the product labeling.
-
CLINICAL_TRIALS trial_result · 2023-10-05Clinical Trial Update: Dexmetomidine With Erector Spinae Plane Block in Cholecystectomy [Phase 1, Phase 2]
A completed phase 1/2 trial evaluating dexmetomidine in an erector spinae plane block for laparoscopic cholecystectomy.
-
FDA approval · 2022-11-22FDA Approved: SINCALIDE — Original Application (MAIA Pharmaceuticals, Inc.)
FDA approved an Original Application for Sincalide (sincalide) by MAIA Pharmaceuticals, Inc., authorizing its use as a diagnostic agent for …
-
CLINICAL_TRIALS research · 2019-01-25Clinical Trial Update: Cholecystocholangiography by Direct Intragallbladder Injection of ICG [NA]
A clinical trial update describes using direct intragallbladder injection of indocyanine green to perform cholecystocholangiography during c…
-
CLINICAL_TRIALS trial_result · 2018-07-09Clinical Trial Update: Laparoscopy-assisted ERCP in Patients With Altered Gastric Anatome
This report summarizes a completed clinical trial evaluating laparoscopy-assisted ERCP in patients with altered gastric anatomy to assess fe…
-
FDA approval · 2018-02-09FDA Approved: KINEVAC — Supplemental Application (Bracco Diagnostics Inc.)
The FDA approved a supplemental application for KINEVAC (Sincalide) from Bracco Diagnostics, updating labeling to support its diagnostic use…
-
CLINICAL_TRIALS trial_result · 2017-04-10Clinical Trial Update: CO2 vs. Air Insufflation for Endoscopic Ultrasound
A completed clinical trial from the University of Bologna comparing CO2 versus air insufflation during endoscopic ultrasound to evaluate saf…
-
CLINICAL_TRIALS trial_result · 2017-03-30Clinical Trial Update: Clinical Utility of ERCP Guided Cholangiopancreatoscopy With the SpyGlass DS [NA]
This clinical trial evaluated the clinical utility of ERCP-guided cholangiopancreatoscopy using the SpyGlass DS system for biliary tract dis…
-
FDA approval · 2016-02-17FDA Approved: KINEVAC — Supplemental Application (Bracco Diagnostics Inc.)
FDA approved a supplemental application for KINEVAC (sincalide) submitted by Bracco Diagnostics Inc.
-
CLINICAL_TRIALS research · 2016-01-07Clinical Trial Update: Deep Neuromuscular Block and Sugammadex Versus Standard of Care on Quality of Recovery in Patient Undergo Elective Laparoscopic Cholecystectomy [Phase 4]
A Phase 4 trial comparing deep neuromuscular blockade with sugammadex reversal versus standard care in elective laparoscopic cholecystectomy…
-
CLINICAL_TRIALS withdrawal · 2015-12-03Clinical Trial Update: Endo-biliary Laser Excision of Biliary Stenoses [NA]
The clinical trial Endo-biliary Laser Excision of Biliary Stenoses has been withdrawn.
-
FDA approval · 2015-09-10FDA Approved: CHOLETEC — Supplemental Application (Bracco Diagnostics Inc)
FDA approved a supplemental application for CHOLETEC (mebrofenin) submitted by Bracco Diagnostics Inc. This entry notes the supplemental app…
-
FDA approval · 2015-08-18FDA Approved: KINEVAC — Supplemental Application (Bracco Diagnostics Inc.)
FDA approved a supplemental application for KINEVAC (sincalide) submitted by Bracco Diagnostics Inc., indicating approval of changes under a…
-
FDA approval · 2014-07-18FDA Approved: KINEVAC — Supplemental Application (Bracco Diagnostics Inc.)
FDA approved a supplemental application for KINEVAC (sincalide) from Bracco Diagnostics Inc., representing a supplemental approval related t…
-
CLINICAL_TRIALS trial_result · 2013-07-31Clinical Trial Update: Effect of a Fatty Meal on Endoscopic Retrograde Cholangiopancreatography (ERCP) [Phase 1, Phase 2]
This document reports on a completed Phase 1/Phase 2 clinical trial evaluating whether a fatty meal influences ERCP procedure outcomes in bi…
-
CLINICAL_TRIALS trial_result · 2011-11-18Clinical Trial Update: The Analgesic Efficacy of Transversus Abdominis Plane Block After Laparoscopic Cholecystectomy [Phase 4]
Phase 4 trial completed evaluating the analgesic effectiveness of the transversus abdominis plane (TAP) block after laparoscopic cholecystec…
-
FDA approval · 2010-08-12FDA Approved: KIT FOR THE PREPARATION OF TECHNETIUM TC 99M MEBROFENIN — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approves a supplemental application for a kit to prepare Technetium-99m mebrofenin for hepatobiliary imaging, manufactured by Sun Pharma…